Search Thermo Fisher Scientific
图: 1 / 1
The immunogen is 100% (10/12) homologous to SARS-COV-2 (COVID-19) Envelop protein. The cross reactivity is not empirically tested.
Suggested positive control: recombinant fusion protein.
A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: Coronavirus; COVID; COVID 19; COVID-19; COVID19; SARS; SARS Coronavirus; SARS CoV; SARS CoV-2; SARS CoV2; SARS-CoV-2; SARS-CoV2; SARS-E